Navigation Links
Tianyin Pharmaceutical Co., Inc. to Host Fiscal Year 2008 Third Quarter Earnings Conference Call on Thursday, May 15, 2008 at 9:00 a.m. EDT
Date:5/14/2008

CHENGDU, China, May 14 /Xinhua-PRNewswire-FirstCall/ -- Tianyin Pharmaceutical, Co., Inc., (OTC Bulletin Board: TYNP), a manufacturer and supplier of modernized traditional Chinese medicine (''TCM'') based in Chengdu, China, today announced that Mr. Stewart Lor, a member of the Board of Directors, will host a conference call to update shareholders on the 2008 third quarter financial results.

The conference call will take place at 9:00 a.m. EDT, on Thursday, May 15, 2008. Interested participants should call 800-762-9058 within the United States, or US + 1-480-629-9039 if calling internationally. The conference ID is 3879213. It is advisable to dial in approximately 5-10 minutes prior to 9:00 a.m. EDT.

If you are unable to participate in the call at the scheduled time, a playback will be available on Thursday, May 15, 2008 at 12:00 p.m. EDT through Thursday, May 29, 2008 at 11:59 p.m. EDT. To listen to the playback, please call 800-406-7325 from within the United States, or US +1-303-590-3030 internationally. Please use pass code 3879213 for the replay.

About Tianyin Pharmaceuticals

Tianyin is a manufacturer and supplier of modernized Traditional Chinese Medicine ("TCM") in China. It was established in 1994 and acquired by the current management team in August 2003. It has a comprehensive product portfolio of 34 modernized TCMs in the market, 22 of which are listed in the highly selective National Medicine Catalog of the National Medical Insurance Program. Tianyin owns and operates two GMP manufacturing facilities and an R&D platform supported by leading Chinese academic institutions. The Company has a pipeline of 51 pharmaceutical products pending approval. Tianyin has an extensive nationwide distribution network throughout China with a sales force of 523 salespeople. Tianyin is headquartered in Chengdu, Sichuan Province with two manufacturing facilities and a total of 1,187 employees. Tianyin achieved revenue of $20.4 million and net income of $3.95 million in FY2007 ending June 30, 2007.

Safe Harbor Statement

The Statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, government approval processes, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed in the Company's filings with the Securities and Exchange Commission.

For more information, please contact:

For the Company:

Allen Tang, Ph.D., MBA, Assistant to the CEO

Tel: +86-158-2122-5642

Email: Allen.y.tang@gmail.com

Investors:

HC International, Inc.

Alan Sheinwald

Tel: +1-914-669-0222

Email: Alan.Sheinwald@hcinternational.net


'/>"/>
SOURCE Tianyin Pharmaceutical, Co., Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Tianyin Pharmaceutical to Present at Roth Third Annual China Discovery Tour in Beijing on May 20, 2008 at 12:40 p.m. Beijing Time
2. Viscorp, Inc. Announces Name Change to Tianyin Pharmaceutical Co Inc. and Begins Trading Under the Ticker OTC BB: TYNP
3. Simcere Pharmaceutical Group Announces SFDA Approval of First-to-Market Generic Biapenem Injection Anxin
4. MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results
5. Ferring Pharmaceuticals EUFLEXXA(R) to Serve as a Sponsor for the Babolat World Tennis Classic
6. Sunesis Pharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
7. MAP Pharmaceuticals Reports First Quarter of 2008 Financial Results
8. Benda Pharmaceutical Appoints Jun Tang to Board of Directors
9. Alseres Pharmaceuticals to Host 2008 First Quarter Conference Call
10. Shengtai Pharmaceutical, Inc. Announces Conference Call to Discuss Third Quarter Results of Fiscal Year 2008
11. Par Pharmaceutical Reports First Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... ... and financial planning services to communities in the greater Birmingham area, is joining ... resources to underprivileged young people in the region. , The Chris Hammond Youth ...
(Date:7/21/2017)... , ... July 21, 2017 , ... Bernard R. Bach, ... President of the American Orthopaedic Society of Sports Medicine (AOSSM) , received the ... the AOSSM Annual Meeting in Toronto, Canada. This prestigious award is given annually to ...
(Date:7/21/2017)... ... , ... “Kids aren't born knowing how to regulate their emotions any more ... of St. Louis-based positive education company Generation Mindful. To help with that daunting task, ... , The kit uses colorful, engaging and educational illustrations and games to teach ...
(Date:7/21/2017)... ... July 21, 2017 , ... How physicians and athletic trainers ... say researchers presenting their work at the American Orthopaedic Society for Sports ... evaluating the patterns of change in concussion symptom presentation, diagnostic tools used and ...
(Date:7/20/2017)... Texas (PRWEB) , ... July 20, 2017 , ... ... litigation law firm headquartered in Houston, is pleased to announce their expansion to ... of affordable housing experience, directors Alysse Hollis and Ronald Bell, and of counsels, ...
Breaking Medicine News(10 mins):
(Date:7/5/2017)... Analytical, a company of over 2,000 employees and a leader in environmental and ... further solidifying their position as the top American owned and operated environmental testing ... ... ... Juliet, TN , enhances Pace Analytical,s capability as an innovative full service ...
(Date:7/1/2017)... , June 30, 2017 Zimmer Biomet Holdings, Inc. ... and earnings conference call will be broadcast live over the ... Time.  A news release detailing the quarterly results will be ... the conference call. The live audio webcast can ... http://investor.zimmerbiomet.com . It will be archived for replay following the ...
(Date:6/30/2017)... SAN DIEGO , June 30, 2017  AVACEN Medical (AVACEN) ... Access Journal. The research describes the use of its AVACEN ... by those suffering from fibromyalgia. ... AVACEN Medical ... Fibromyalgia is characterized by chronic widespread pain. It affects approximately 200 to ...
Breaking Medicine Technology: